- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 15-01-2026: Press Release
15-01-2026 | 01:16 pm
15-01-2026 | 01:16 pm
Zydus secured USFDA nod for Eltrombopag Tablets, targeting low platelet count. This drug recorded annual US sales of ~$10,480 Cr (USD 1,262.5 mn). A key approval, boosting Zydus's product portfolio and US market opportunity.
No comments yet. Be the first to comment!